CLOROX CO quarterly report, Q1 FY2011

The Clorox Company — Form 10-Q Summary

Reporting period: Three months ended September 30, 2010 (first quarter of fiscal 2011). Unaudited results; dollar amounts are in millions except per-share data.

Financial performance

MetricQ1 FY2011Q1 FY2010
Net sales$1,266$1,303
Gross profit / margin$561 / 44.3%$583 / 44.7%
Continuing-operations pretax earnings$202$217
Continuing-operations earnings$140$140
Net earnings$216$157
Diluted EPS, continuing operations / total$0.98 / $1.52$0.99 / $1.11
Operating cash flow, continuing operations$126$77
Capital expenditures$34$34

Net earnings included a $60 deferred tax benefit related to the planned Auto Businesses sale; discontinued operations contributed $76 of earnings versus $17 a year earlier. Excluding that benefit, continuing-operations earnings were flat, while diluted continuing-operations EPS declined one cent. Cash and equivalents were $286 at quarter-end, up $199 from June 30, 2010. Total debt was $2,930, including $300 of senior notes due February 2011. The company reported a 2.40 debt-to-EBITDA covenant ratio and compliance with covenants.

Changes and operating drivers

  • Sales fell 3%; volume declined 2%. Management cited lower shipments in Glad food storage, Scoop Away cat litter, Kingsford charcoal, Hidden Valley bottled dressings and disinfecting products, including a comparison against prior-period H1N1-related shipments.
  • Gross margin declined 0.4 percentage points. Unfavorable commodities and other items reduced margin by about 2.4 percentage points, largely offset by cost savings of about 2.0 points.
  • Continuing-operations diluted EPS was affected by commodity costs, higher selling and administrative expenses, lower sales and unfavorable foreign exchange, particularly in Venezuela; cost savings and price increases partly offset these pressures. Venezuela currency effects reduced diluted EPS by $0.07, versus $0.04 a year earlier.
  • Segment sales and pretax earnings: Cleaning $449 and $121 (sales down 1%, earnings up 2%); Household $354 and $53 (down 7% and 4%); Lifestyle $201 and $58 (up 1%, down 12%); International $262 and $40 (down 2% and 7%).

Liquidity, transactions and outlook

Operating cash flow from continuing operations increased to $126, primarily due to working-capital changes and an $18 lower pension contribution. Cash flow from all operations was $148. Commercial paper outstanding was $503; the company had an undrawn $1,100 revolving credit facility and said it planned to refinance the $300 notes due February 2011. Current liabilities exceeded current assets excluding assets held for sale by $448.

In September, Clorox agreed to sell substantially all global auto care businesses, including Armor All and STP, to an affiliate of Avista Capital Partners for approximately $780 in cash, subject to closing adjustments, approvals and other conditions. Closing was expected by calendar year-end 2010. The company anticipated using net proceeds for share repurchases and projected repurchasing 12–13 million shares over the next two fiscal quarters, including dilution-offset purchases.

Management described liquidity as strong and expected operating cash flows, commercial-paper access, the credit facility and planned refinancing to meet foreseeable operating and capital needs. This is not a specific earnings or sales forecast. Key stated risks include commodity and energy costs, foreign exchange and inflation, competition and consumer response to pricing, customer concentration, execution of cost-saving programs and the auto-care divestiture, and legal, environmental and tax matters.

Risks, contingencies and unusual items

  • The $60 tax benefit associated with the planned sale materially boosted reported net earnings; the transaction remained subject to closing conditions.
  • Environmental remediation liability was $16, largely related to a Michigan site where Clorox is jointly and severally liable and has a cost-sharing arrangement with Ford. Potential additional exposure was not estimable.
  • Goodwill and indefinite-lived intangible impairment reviews identified no impairment, but the Burt’s Bees reporting unit’s estimated fair value exceeded carrying value by approximately 5%; a shortfall in growth or margin assumptions could create impairment risk.
  • Wal-Mart and its affiliates represented 27% of consolidated sales. The filing also noted restrictions on U.S. dollars available for Venezuelan operations and related currency and supply impacts.
  • Management stated disclosure controls were effective and reported no material change in internal control over financial reporting during the quarter.

Important facts for investors to verify

  • Whether the auto-care sale closed, final proceeds after working-capital adjustments, and the actual use of proceeds.
  • Whether the planned refinancing of the February 2011 notes was completed and on what terms.
  • Subsequent share repurchases versus the 12–13 million-share projection and their effect on debt and EPS.
  • Whether commodity, Venezuela foreign-exchange, inflation and volume pressures persisted, and whether cost savings offset them.
  • Developments in environmental remediation exposure, tax audits and Burt’s Bees goodwill valuation.